Publications acknowledging the platform
2025
Brachs S, et al. Robust noninvasive detection of hyperglycemia in mouse models of metabolic dysregulation using the novel Urination Index biomarker. Lab Anim (NY). 2025 Dec;54(12):379-389. doi: 10.1038/s41684-025-01648-8. Epub 2025 Nov 21.
Dall M, et al. Hepatocyte dedifferentiation in 2D culture reveals extensive transcriptomic and proteomic rewiring. Hepatol Commun. 2025 Oct 7;9(11):e0795. doi: 10.1097/HC9.0000000000000795.
Holm SK, et al. Sustained Weight Loss With Combined LEAP2 and Semaglutide Treatment in Mice. Diabetes. 2025 Jul 1:db241056. doi: 10.2337/db24-1056. Epub ahead of print.
Chubanava S, et al. NAD depletion in skeletal muscle does not compromise muscle function or accelerate aging. Cell Metab. 2025 Apr 30:S1550-4131(25)00212-8. doi: 10.1016/j.cmet.2025.04.002. Epub ahead of print.
Ranea-Robles P, et al. Time-Resolved Effects of Short-term Overfeeding on Energy Balance in Mice. Diabetes. 2025 Apr 1;74(4):502-513. doi: 10.2337/db24-0289.
Gil CRE, et al. Food insecurity promotes adiposity in mice. Obesity (Silver Spring). 2025 Mar 23. doi: 10.1002/oby.24259. Epub ahead of print.
Lansbury EL, et al. Neurons Co-Expressing GLP-1, CCK, and PYY Receptors Particularly in Right Nodose Ganglion and Innervating Entire GI Tract in Mice. Int J Mol Sci. 2025 Feb 26;26(5):2053. doi: 10.3390/ijms26052053.
Ashcroft SP, et al. Enhanced metabolic adaptations following late dark phase wheel running in high-fat diet-fed mice. Mol Metab. 2025 May;95:102116. doi: 10.1016/j.molmet.2025.102116. Epub 2025 Feb 22.
2024
Sass F, et al. NK2R control of energy expenditure and feeding to treat metabolic diseases. Nature. 2024 Nov;635(8040):987-1000. doi: 10.1038/s41586-024-08207-0. Epub 2024 Nov 13.
Petersen J, et al. GLP-1-directed NMDA receptor antagonism for obesity treatment. Nature. 2024 May;629(8014):1133-1141. doi: 10.1038/s41586-024-07419-8. Epub 2024 May 15.
Pendergrast LA, et al. Metabolic plasticity and obesity-associated changes in diurnal postexercise metabolism in mice. Metabolism. 2024 Mar 11:155834. doi: 10.1016/j.metabol.2024.155834. Epub ahead of print.
Fadahunsi N, et al. Targeting postsynaptic glutamate receptor scaffolding proteins PSD-95 and PICK1 for obesity treatment. Sci Adv. 2024 Mar;10(9):eadg2636. doi: 10.1126/sciadv.adg2636. Epub 2024 Mar 1.
Lund C, et al. Protection against overfeeding-induced weight gain is preserved in obesity but does not require FGF21 or MC4R. Nat Commun. 2024 Feb 8;15(1):1192. doi: 10.1038/s41467-024-45223-0.
2023
Lund J, et al. The anorectic and thermogenic effects of pharmacological lactate in male mice are confounded by treatment osmolarity and co-administered counterions. Nat Metab. 2023 Apr;5(4):677-698. doi: 10.1038/s42255-023-00780-4. Epub 2023 Apr 13.
Basse AL, et al. NAMPT-dependent NAD+ biosynthesis controls circadian metabolism in a tissue-specific manner. Proc Natl Acad Sci U S A. 2023 Apr 4;120(14):e2220102120. doi: 10.1073/pnas.2220102120. Epub 2023 Mar 30.
Peluso AA, et al. Oral supplementation of nicotinamide riboside alters intestinal microbial composition in rats and mice, but not humans. NPJ Aging. 2023 Apr 3;9(1):7. doi: 10.1038/s41514-023-00106-4.
Falk S, et al. GLP-1 and nicotine combination therapy engages hypothalamic and mesolimbic pathways to reverse obesity. Cell Rep. 2023 May 30;42(5):112466. doi: 10.1016/j.celrep.2023.112466. Epub 2023 May 5.
2022
Damgaard MV, et al. Intravenous nicotinamide riboside elevates mouse skeletal muscle NAD+ without impacting respiratory capacity or insulin sensitivity. iScience. 2022 Feb 2;25(2):103863. doi: 10.1016/j.isci.2022.103863.
2021
Grevengoed TJ, et al. An abundant biliary metabolite derived from dietary omega-3 polyunsaturated fatty acids regulates triglycerides. J Clin Invest. 2021 Mar 15;131(6):e143861. doi: 10.1172/JCI143861.
Lubberding AF, et al. Age-dependent transition from islet insulin hypersecretion to hyposecretion in mice with the long QT-syndrome loss-of-function mutation Kcnq1-A340V. Sci Rep. 2021 Jun 10;11(1):12253. doi: 10.1038/s41598-021-90452-8.
Sveidahl Johansen O, et al. Lipolysis drives expression of the constitutively active receptor GPR3 to induce adipose thermogenesis. Cell. 2021 Jun 24;184(13):3502-3518.e33. doi: 10.1016/j.cell.2021.04.037. Epub 2021 May 27.
Tozzi M, et al. Dynamic interplay between AfadinS1795 phosphorylation and diet regulates glucose homeostasis in obese mice. J Physiol. 2022 Feb;600(4):885-902. doi: 10.1113/JP281657. Epub 2021 Sep 1.
Gonzalez-Franquesa A, et al. Discovery of thymosin β4 as a human exerkine and growth factor. Am J Physiol Cell Physiol. 2021 Nov 1;321(5):C770-C778. doi: 10.1152/ajpcell.00263.2021. Epub 2021 Sep 8.
Dall M, et al. Hepatocyte-specific perturbation of NAD+ biosynthetic pathways in mice induces reversible nonalcoholic steatohepatitis-like phenotypes. J Biol Chem. 2021 Dec;297(6):101388. doi: 10.1016/j.jbc.2021.101388. Epub 2021 Nov 8.